UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Half-life extended biotherapeutics

Expert opinion on biological therapy, 2016-07, Vol.16 (7), p.903-915

Kontermann, Roland E.

2016

Volltextzugriff (PDF)

Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US

Current medical research and opinion, 2019-07, Vol.35 (7), p.1241-1256

2019

Volltextzugriff (PDF)

Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review

Drug delivery, 2020-01, Vol.27 (1), p.40-53

2020

Volltextzugriff (PDF)

Albumin-bound paclitaxel: a next-generation taxane

Expert opinion on pharmacotherapy, 2006-06, Vol.7 (8), p.1041-1053

Gradishar, William J

2006

Volltextzugriff (PDF)

Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis

Acta oncologica, 2020-06, Vol.59 (6), p.705-712

2020

Volltextzugriff (PDF)

Triphenylphosphine-docetaxel conjugate-incorporated albumin nanoparticles for cancer treatment

Nanomedicine (London, England), 2018-02, Vol.13 (3), p.325-338

2018

Volltextzugriff (PDF)

Addition of sintilimab to nanoparticle albumin-bound paclitaxel and S-1 as adjuvant therapy in stage IIIC gastric cancer

Future oncology (London, England), 2022-01, Vol.18 (2), p.139-148

2022

Volltextzugriff (PDF)

Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX

Expert review of clinical pharmacology, 2017-10, Vol.10 (10), p.1153-1160

2017

Volltextzugriff (PDF)

Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer

Cancer biology & therapy, 2015-03, Vol.16 (3), p.438-449

2015

Volltextzugriff (PDF)

Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china

Expert review of pharmacoeconomics & outcomes research, 2021-07, Vol.21 (4), p.691-697

2021

Volltextzugriff (PDF)

RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy

Cancer biology & therapy, 2012-02, Vol.13 (4), p.206-215

2012

Volltextzugriff (PDF)

Efficacy of nab-paclitaxel in treating metastatic melanoma

Expert opinion on pharmacotherapy, 2019-03, Vol.20 (5), p.495-500

Specenier, Pol

2019

Volltextzugriff (PDF)

Body Composition Adjusted Dosing of Gemcitabine-Nab-Paclitaxel in Pancreatic Cancer Does Not Predict Toxicity Compared to Body Surface Area Dosing

Nutrition and cancer, 2019-05, Vol.71 (4), p.624-628

2019

Volltextzugriff (PDF)

The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death

Drug delivery, 2021-01, Vol.28 (1), p.800-813

2021

Volltextzugriff (PDF)

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer

Expert opinion on pharmacotherapy, 2012-02, Vol.13 (3), p.395-406

2012

Volltextzugriff (PDF)

Metabolism of the taxanes including nab-paclitaxel

Expert opinion on drug metabolism & toxicology, 2015-05, Vol.11 (5), p.691-702

Joerger, Markus

2015

Volltextzugriff (PDF)

An update on the pathogenesis and clinical management of cirrhosis with refractory ascites

Expert review of gastroenterology & hepatology, 2019-04, Vol.13 (4), p.293-305

2019

Volltextzugriff (PDF)

Enhanced cell killing and apoptosis of oral squamous cell carcinoma cells with ultrasound in combination with cetuximab coated albumin microbubbles

Journal of drug targeting, 2018-03, Vol.26 (3), p.278-288

2018

Volltextzugriff (PDF)

Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer

Journal of medical economics, 2017-04, Vol.20 (4), p.345-352

2017

Volltextzugriff (PDF)

Albumin-based drug delivery using cysteine 34 chemical conjugates - important considerations and requirements

Therapeutic delivery, 2017-07, Vol.8 (7), p.511-519

2017

Volltextzugriff (PDF)

Penetration depth, concentration and efficiency of transdermal α-arbutin delivery after ultrasound treatment with albumin-shelled microbubbles in mice

Drug delivery, 2016-09, Vol.23 (7), p.2173-2182

2016

Volltextzugriff (PDF)

Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study

Leukemia & lymphoma, 2018-02, Vol.59 (2), p.357-362

2018

Volltextzugriff (PDF)

Use of intravenous fluids/solutions: a narrative review

Current medical research and opinion, 2017-03, Vol.33 (3), p.459-471

2017

Volltextzugriff (PDF)

A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck

Cancer investigation, 2017-01, Vol.35 (1), p.23-31

2017

Volltextzugriff (PDF)

Nanoparticle albumin-bound-paclitaxel: a limited improvement under the current therapeutic paradigm of pancreatic cancer

Expert opinion on pharmacotherapy, 2015-05, Vol.16 (7), p.943-947

2015

Volltextzugriff (PDF)

1 – 25 von 551

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Current Content Access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(517)
Mit Volltextzugriff
(363)

Publikationsform

Artikel
(551)

Sprache

Englisch
(551)

Erscheinungsjahr

n.n

Thema

Science & Technology
(493)
Life Sciences & Biomedicine
(472)
Animals
(326)
Humans
(275)
Pharmacology & Pharmacy
(242)
Biological And Medical Sciences
(216)
Male
(203)
Medical Sciences
(187)
Female
(182)
Pharmacology. Drug Treatments
(140)
Physical Sciences
(114)
General Pharmacology
(113)
Pharmaceutical Technology. Pharmaceutical Industry
(113)
Particle Size
(107)
Engineering
(104)
Technology
(104)
Serum Albumin, Bovine - Administration & Dosage
(100)
Rats
(97)
Chemistry
(96)
Chemistry, Applied
(92)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Half-life extended biotherapeutics

Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US

Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review

Albumin-bound paclitaxel: a next-generation taxane

Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis

Triphenylphosphine-docetaxel conjugate-incorporated albumin nanoparticles for cancer treatment

Addition of sintilimab to nanoparticle albumin-bound paclitaxel and S-1 as adjuvant therapy in stage IIIC gastric cancer

Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX

Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer

Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china

RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy

Efficacy of nab-paclitaxel in treating metastatic melanoma

Body Composition Adjusted Dosing of Gemcitabine-Nab-Paclitaxel in Pancreatic Cancer Does Not Predict Toxicity Compared to Body Surface Area Dosing

The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer

Metabolism of the taxanes including nab-paclitaxel

An update on the pathogenesis and clinical management of cirrhosis with refractory ascites

Enhanced cell killing and apoptosis of oral squamous cell carcinoma cells with ultrasound in combination with cetuximab coated albumin microbubbles

Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer

Albumin-based drug delivery using cysteine 34 chemical conjugates - important considerations and requirements

Penetration depth, concentration and efficiency of transdermal α-arbutin delivery after ultrasound treatment with albumin-shelled microbubbles in mice

Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study

Use of intravenous fluids/solutions: a narrative review

A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck

Nanoparticle albumin-bound-paclitaxel: a limited improvement under the current therapeutic paradigm of pancreatic cancer

Aktive Filter

Suchergebnisse filtern